Sitewide
New nanoparticle vaccine is more effective but less expensive
Good news for public health: Bioengineering researchers from the EPFL in Lausanne, Switzerland, have developed and patented a nanoparticle that can deliver vaccines more effectively, with fewer side effects, and at a fraction of the cost of current vaccine technologies.
Similar Articles On This Topic:
- Drug discovery process more accurate, less expensive using novel mass spectrometry application
- UMMS biomedical researchers develop more reliable, less expensive synthetic graft material
- New 'electronic glue' promises less expensive semiconductors
- New growth inhibitors more effective in plants, less toxic to people
- Study finds expensive procedure no more effective than medical therapy to prevent strokes
Popular Today:
Science 2.0:
Recent Articles:
Read Us On Your Kindle:
Create Your Own Releases:
Post new comment